Literature DB >> 15748829

Endogenous aromatization of testosterone results in growth stimulation of the human MCF-7 breast cancer cell line.

K Sonne-Hansen1, A E Lykkesfeldt.   

Abstract

Estrogens produced within breast tumors may play a pivotal role in growth stimulation of the breast cancer cells. However, it is elusive whether the epithelial breast cancer cells themselves synthesize estrogens, or whether the surrounding tumor stromal cells synthesize and supply the cancer cells with estrogen. The aromatase enzyme catalyzes the estrogen production, aromatizing circulating androgens into estrogens. The aim of this study was to investigate aromatase expression and function in a model system of human breast cancer, using the estrogen responsive human MCF-7 breast cancer cell line. Cells were cultured in a low estrogen milieu and treated with estrogens, aromatizable androgens or non-aromatizable androgens. Cell proliferation, expression of estrogen-regulated proteins and aromatase activity were investigated. The MCF-7 cell line was observed to express sufficient aromatase enzyme activity in order to aromatize the androgen testosterone, resulting in a significant cell growth stimulation. The testosterone-mediated growth effect was completely inhibited by the aromatase inhibitors letrozole and 4-hydroxy-androstenedione. Expression studies of estrogen-regulated proteins confirmed that testosterone was aromatized to estrogen in the MCF-7 cells. Thus, the results indicate that epithelial breast cancer cells possess the ability to aromatize circulating androgens to estrogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15748829     DOI: 10.1016/j.jsbmb.2004.11.005

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  22 in total

1.  The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum.

Authors:  Amin Esfahani; Cyril W C Kendall; Balachandran Bashyam; Michael C Archer; David J A Jenkins
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-10-07       Impact factor: 2.416

Review 2.  Androgens in human breast carcinoma.

Authors:  Takashi Suzuki; Yasuhiro Miki; Kiyoshi Takagi; Hisashi Hirakawa; Takuya Moriya; Noriaki Ohuchi; Hironobu Sasano
Journal:  Med Mol Morphol       Date:  2010-08-04       Impact factor: 2.309

3.  Increased 5α-reductase type 2 expression in human breast carcinoma following aromatase inhibitor therapy: the correlation with decreased tumor cell proliferation.

Authors:  Niramol Chanplakorn; Pongsthorn Chanplakorn; Takashi Suzuki; Katsuhiko Ono; Lin Wang; Monica S M Chan; Loo Wing; Christopher C P Yiu; Louis Wing-Cheong Chow; Hironobu Sasano
Journal:  Horm Cancer       Date:  2011-02       Impact factor: 3.869

4.  Endogenous sex hormones and breast density in young women.

Authors:  Seungyoun Jung; Frank Z Stanczyk; Brian L Egleston; Linda G Snetselaar; Victor J Stevens; John A Shepherd; Linda Van Horn; Erin S LeBlanc; Kenneth Paris; Catherine Klifa; Joanne F Dorgan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-11-04       Impact factor: 4.254

5.  Mammographic Density and Circulating Sex Hormones: a Cross-Sectional Study in Postmenopausal Korean Women.

Authors:  Kayoung Lee; Jung Eun Yoo; Tuong Linh Nguyen; John Llewelyn Hopper; Yun-Mi Song
Journal:  Horm Cancer       Date:  2018-07-24       Impact factor: 3.869

6.  Intratumoral estrogen concentration and expression of estrogen-induced genes in male breast carcinoma: comparison with female breast carcinoma.

Authors:  Kiyoshi Takagi; Takuya Moriya; Masafumi Kurosumi; Kimako Oka; Yasuhiro Miki; Akiko Ebata; Takashi Toshima; Shoji Tsunekawa; Hiroyuki Takei; Hisashi Hirakawa; Takanori Ishida; Shin-Ichi Hayashi; Junichi Kurebayashi; Hironobu Sasano; Takashi Suzuki
Journal:  Horm Cancer       Date:  2012-10-18       Impact factor: 3.869

7.  The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance.

Authors:  Matthew J Sikora; Kevin E Cordero; Jose M Larios; Michael D Johnson; Marc E Lippman; James M Rae
Journal:  Breast Cancer Res Treat       Date:  2008-06-04       Impact factor: 4.872

8.  Selective inhibition of aromatase by a dihydroisocoumarin from Xyris pterygoblephara.

Authors:  Denise C Endringer; Keller G Guimarães; Tamara P Kondratyuk; John M Pezzuto; Fernão C Braga
Journal:  J Nat Prod       Date:  2008-05-08       Impact factor: 4.050

9.  Suppression of aromatase in human breast cells by a cyclooxygenase-2 inhibitor and its analog involves multiple mechanisms independent of cyclooxygenase-2 inhibition.

Authors:  Bin Su; Edgar S Díaz-Cruz; Serena Landini; Robert W Brueggemeier
Journal:  Steroids       Date:  2007-10-18       Impact factor: 2.668

10.  Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells.

Authors:  C Martínez-Campa; A González; M D Mediavilla; C Alonso-González; V Alvarez-García; E J Sánchez-Barceló; S Cos
Journal:  Br J Cancer       Date:  2009-09-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.